UngTerapi ApS — Credit Rating and Financial Key Figures
CVR number: 38749463
Kvægtorvsgade 1, 1710 København V
admin@ungterapi.dk
tel: 40817127
https://ungterapi.dk
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | 1 775.47 | 2 285.48 | 3 909.02 | 3 320.91 | 3 509.21 |
Employee benefit expenses | -1 208.36 | -1 562.46 | -3 004.28 | -3 479.35 | -3 801.76 |
Total depreciation | -29.90 | -29.90 | -29.90 | -29.74 | -28.07 |
EBIT | 537.22 | 693.12 | 874.84 | - 188.18 | - 320.62 |
Other financial income | 15.89 | 92.82 | 58.28 | 77.01 | 41.34 |
Other financial expenses | -0.11 | -1.73 | -3.27 | -1.50 | -5.21 |
Pre-tax profit | 553.00 | 784.22 | 929.85 | - 112.66 | - 284.50 |
Income taxes | - 123.01 | - 172.75 | - 205.58 | 23.42 | 59.98 |
Net earnings | 429.99 | 611.46 | 724.26 | -89.24 | - 224.51 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Machinery and equipment | 117.61 | 87.71 | 57.81 | 28.07 | |
Tangible assets total | 117.61 | 87.71 | 57.81 | 28.07 | |
Other receivables | 213.18 | ||||
Investments total | 213.18 | ||||
Long term receivables total | |||||
Inventories total | |||||
Current trade debtors | 73.51 | 38.38 | 11.40 | 115.54 | 113.54 |
Current amounts owed by group member comp. | 122.95 | 1 521.94 | 2 132.67 | 1 062.78 | 1 125.59 |
Prepayments and accrued income | 5.80 | 40.45 | 32.89 | 80.40 | 94.60 |
Current other receivables | 0.31 | 34.76 | 9.50 | ||
Current deferred tax assets | 21.11 | 61.61 | |||
Short term receivables total | 202.58 | 1 635.53 | 2 176.95 | 1 279.83 | 1 404.85 |
Cash and bank deposits | 724.84 | 56.01 | 18.31 | 11.03 | 10.83 |
Cash and cash equivalents | 724.84 | 56.01 | 18.31 | 11.03 | 10.83 |
Balance sheet total (assets) | 1 258.20 | 1 779.24 | 2 253.07 | 1 318.93 | 1 415.68 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
Share premium account | 40.94 | ||||
Shares repurchased | 600.00 | 900.00 | |||
Retained earnings | 4.66 | - 124.42 | - 412.96 | 311.30 | 222.06 |
Profit of the financial year | 429.99 | 611.46 | 724.26 | -89.24 | - 224.51 |
Shareholders equity total | 525.58 | 1 137.04 | 1 261.30 | 272.06 | 47.55 |
Provisions | 7.37 | 5.42 | 2.31 | ||
Non-current liabilities total | |||||
Current loans from credit institutions | 55.32 | 393.25 | 680.01 | ||
Advances received | 118.27 | 19.40 | |||
Current trade creditors | 152.19 | 228.75 | 296.24 | 168.49 | 216.70 |
Current owed to participating | 16.96 | 18.67 | 19.42 | 19.89 | 20.69 |
Short-term deferred tax liabilities | 123.42 | 174.71 | 383.40 | ||
Other non-interest bearing current liabilities | 314.40 | 214.65 | 215.68 | 465.23 | 450.73 |
Current liabilities total | 725.25 | 636.78 | 989.46 | 1 046.87 | 1 368.13 |
Balance sheet total (liabilities) | 1 258.20 | 1 779.24 | 2 253.07 | 1 318.93 | 1 415.68 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.